VGLL4 levels in cancer cells are typically lower compared to normal tissues, and reduced expression of VGLL4 is often associated with poor survival outcomes in numerous cancers, including lung, gastric, breast, colorectal, bladder, pancreatic adenocarcinoma, and esophageal squamous cancer. This evidence concerns the gene VGLL4 and pancreatic adenocarcinoma.